共 50 条
Virtual Reality Cognitive Remediation in Older Adults with Bipolar Disorder: The Effects on Cognitive Performance and Depression in a Feasibility Randomized Controlled Trial
被引:0
|作者:
Primavera, Diego
[1
]
Aviles Gonzalez, Cesar
[1
,2
]
Perra, Alessandra
[1
]
Kalcev, Goce
[3
]
Cantone, Elisa
[1
]
Cossu, Giulia
[1
]
Holzinger, Anita
[4
]
Carta, Mauro Giovanni
[1
]
Sancassiani, Federica
[1
]
机构:
[1] Univ Cagliari, Dept Med Sci & Publ Hlth, I-09042 Cagliari, Italy
[2] Univ Popular Cesar, Dept Nursing, Valledupar 200001, Colombia
[3] Natl Alliance Neuromuscular Dis & Neurosci GANGL S, Skopje 1000, North Macedonia
[4] Univ Wien, Dept Med, Spitalgasse 23, A-1090 Vienna, Austria
来源:
关键词:
cognitive remediation;
virtual reality;
advanced technology laboratory;
elderly;
SEVERE MENTAL-ILLNESS;
CARDIOVASCULAR-DISEASE;
SOCIAL DETERMINANTS;
METABOLIC SYNDROME;
NORMATIVE VALUES;
DEMENTIA;
STATE;
METAANALYSIS;
IMPAIRMENT;
MORTALITY;
D O I:
10.3390/healthcare12171753
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
Introduction: Dementia, depression, and cardiovascular disease are major public health concerns for older adults, requiring early intervention. This study investigates whether a virtual reality cognitive remediation program (VR-CR) can improve cognitive function and depressive symptoms in older adults, and determines the necessary sample size for future studies. Integrated VR and CR interventions have shown promising outcomes in older adults with neurodegenerative and mental health disorders. Methods: This secondary analysis of a randomized controlled trial involves adults aged 58-75 years with bipolar disorder, excluding those with acute episodes, epilepsy, or severe eye diseases. The experimental group received standard treatment plus VR-CR, while the control group received only standard treatment. Results: No baseline differences were found between the experimental and control groups. No significant improvement was observed in the overall cognitive function test (p = 0.897) or in depressive symptoms (p = 0.322). A phase III efficacy study requires a sample size of 28 participants (alpha = 0.05, beta = 0.20). Conclusions: VR-CR can potentially treat depressive symptoms in adults and older adults, but the results support conducting phase III studies to further investigate these outcomes. However, the improvement in cognitive performance in the elderly is less pronounced than in younger individuals.
引用
收藏
页数:10
相关论文